Treatment of chronically depressed patients: A multisite randomized controlled trial testing the effectiveness of ‘Cognitive Behavioral Analysis System of Psychotherapy’(CBASP) for chronic depressions versus usual secondary care.

J.E. Wiersma, D.J.F. van Schaik, P.C. van Oppen, J.P. McCullough, R.A. Schoevers, J.J.M. Dekker, M.B.J. Blom, K. Maas, J.H. Smit, B.W.J.H. Penninx, A.T.F. Beekman

Research output: Contribution to journalArticleAcademicpeer-review

46 Downloads (Pure)

Abstract

Abstract
Background
'Cognitive Behavioral Analysis System of Psychotherapy' (CBASP) is a form of psychotherapy specifically developed for patients with chronic depression. In a study in the U.S., remarkable favorable effects of CBASP have been demonstrated. However, no other studies have as yet replicated these findings and CBASP has not been tested outside the United States. This protocol describes a randomized controlled trial on the effectiveness of CBASP in the Netherlands.

Methods/Design
The purpose of the present paper is to report the study protocol of a multisite randomized controlled trial testing the effectiveness of 'Cognitive Behavioral Analysis System of Psychotherapy' (CBASP) for chronic depression in the Netherlands. In this study, CBASP in combination with medication, will be tested versus usual secondary care in combination with medication. The aim is to recruit 160 patients from three mental health care organizations. Depressive symptoms will be assessed at baseline, after 8 weeks, 16 weeks, 32 weeks and 52 weeks, using the 28-item Inventory for Depressive Symptomatology (IDS). Effect modification by co morbid anxiety, alcohol consumption, general and social functioning and working alliance will be tested. GEE analyses of covariance, controlling for baseline value and center will be used to estimate the overall treatment effectiveness (difference in IDS score) at post-treatment and follow up. The primary analysis will be by 'intention to treat' using double sided tests. An economic analysis will compare the two groups in terms of mean costs and cost-effectiveness from a societal perspective.

Discussion
The study will provide an answer to the question whether the favorable effects of CBASP can be replicated outside the US.
Original languageUndefined/Unknown
Article number18
JournalBMC Psychiatry
Volume8
Issue number1
DOIs
Publication statusPublished - 2008

Cite this